BioTissue Surgical is the leader in amniotic membrane and umbilical cord regenerative tissue therapies and is supported by more than 30 years of research characterizing and preserving the biology and functionality of human Amniotic Membrane (AM) and Umbilical Cord (UC). AM and UC are restorative tissues that carry unique regenerative properties and BioTissue Surgical is the sole provider of a matrix comprised of both human AM and UC. Our extensive research allows us to preserve and deliver the most functional allograft, transplanting the benefits of regenerative healing to adult wound environments.